Position in TBPH
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$255,000
New position
Shares Held
15,000
first reported quarter
Ownership
0.029%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#104
of 180 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026DELTEC ASSET MANAGEMENT LLC holds $28,179,038 across 7 Biotechnology names. TBPH ranks #5 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | OCUL |
Ocular Therapeutix, Inc
|
2,476,197 | $24,316,254 | |
| 2 | MNKD |
Mannkind Corp
|
628,000 | $2,675,280 | |
| 3 | PVLA |
Palvella Therapeutics, Inc.
|
2,400 | $366,768 | |
| 4 | LSTA |
Lisata Therapeutics, Inc.
|
83,197 | $282,869 | |
| 5 | TBPH |
Theravance Biopharma, Inc.
This page
|
15,000 | $255,000 | |
| 6 | JBIO |
Jade Biosciences, Inc.
|
9,436 | $209,667 | |
| 7 | PASG |
Passage BIO, Inc.
|
15,000 | $73,200 |
All Filings in TBPH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $255,000 | 15,000 | Shares | Sole | 2026-07-21 | |
| No filing history on record for this holder in this stock. | ||||||